News

Video

Off-Label Uses for NOACs

Conference|ASHP Midyear Clinical Meeting and Exhibition - American Society of Health System Pharmacists Midyear Clinical Meeting and Exhibition

Katie Greenlee, PharmD, BCPS-AQ Cardiology, of the Cleveland Clinic gives examples of certain off-label uses for NOACs that seem promising.

Katie Greenlee, PharmD, BCPS-AQ Cardiology, of the Cleveland Clinic gives examples of certain off-label uses for NOACs that seem promising.

This video was recorded at the 2015 American Society of Health-System Pharmacists Midyear Meeting.

Related Videos
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
Pharmacy, Advocacy, Opioid Awareness Month | Image Credit: pikselstock - stock.adobe.com
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
Pharmacists, Education, Advocacy, Opioid Awareness Month | Image Credit: Jacob Lund - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen | stock.adobe.com
Related Content
Immunization, Survey, COVID-19, Vaccine, Pharmacists | Image Credit: Talia Mdlungu/peopleimages.com - stock.adobe.com
October 28th 2024

Survey: 8 in 10 Patients Believe Immunization Protects Them From Public Health Threats

Ashley Gallagher, Associate Editor
Public Health Matters podcast logo
September 19th 2024

Public Health Matters: The Difference Between Misinformation and Disinformation, and How Information Can Inform Evidence-Based Decisions

GLP-1, diabetes, obesity | Image Credit: Patrick Bay Damsted - stock.adobe.com
October 28th 2024

Some Disease Burden of Obesity Requires Pharmacotherapy, Not Just Lifestyle Interventions

Ashley Gallagher, Associate Editor
Public Health Matters podcast logo
August 22nd 2024

Public Health Matters: Healthcare Advocate Summit Emphasizes Advocates Have a Voice in Creating Solutions

Pharmacy, Biosimilar, Humira, Stelara | Image Credit: Jacob Lund -stock.adobe.com
October 28th 2024

The Future of Biosimilars: Learning from Prior Mistakes

Mark Campbell, PharmD
Sickle cell disease -- Image credit: Iftikhar alam | stock.adobe.com
October 28th 2024

FDA Grants Orphan Drug Designation to AND017 for the Treatment of Sickle Cell Disease

Gillian McGovern, Assistant Editor